NCT03849781 - The NeoBeat Efficacy Study for Newborns | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

March 8, 2019

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2022

Conditions

Newborn ResuscitationHeart Rate Monitoring

Interventions

DEVICE

NeoBeat with a visible display

NeoBeat (Laerdal Medical) is a CE approved novel heart rate meter, able to detect heart rate in newborns within seconds of birth. The NeoBeat uses ECG dry-electrodes in a snug-fit abdomen-shaped buckle for rapid application around the newborn's abdomen or thorax. It allows healthcare providers to reliably assess heart rate of the newborn immediately after birth and continuously during resuscitation.

Trial Locations (1)

4068

RECRUITING

Stavanger University Hospital, Stavanger